X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12) 12
index medicus (12) 12
oncology (12) 12
hematology, oncology and palliative medicine (11) 11
metastasis (8) 8
adult (7) 7
aged (7) 7
carcinoma, non-small-cell lung - drug therapy (7) 7
chemotherapy (7) 7
female (7) 7
male (7) 7
middle aged (7) 7
lung cancer, non-small cell (6) 6
lung neoplasms - drug therapy (6) 6
analysis (5) 5
lung cancer (5) 5
antineoplastic agents - therapeutic use (4) 4
carcinoma, non-small-cell lung - pathology (4) 4
care and treatment (4) 4
disease (4) 4
protein kinase inhibitors - therapeutic use (4) 4
pyrazoles - therapeutic use (4) 4
pyridines - therapeutic use (4) 4
receptor protein-tyrosine kinases - antagonists & inhibitors (4) 4
brain metastases (3) 3
brain neoplasms - secondary (3) 3
cancer (3) 3
cancer therapies (3) 3
carcinoma, non-small-cell lung - enzymology (3) 3
carcinoma, non-small-cell lung - genetics (3) 3
carcinoma, non-small-cell lung - mortality (3) 3
clinical trials (3) 3
clinical trials as topic (3) 3
drug resistance, neoplasm (3) 3
gene rearrangement (3) 3
genetic aspects (3) 3
inhibitor (3) 3
lung neoplasms - enzymology (3) 3
lung neoplasms - mortality (3) 3
lung neoplasms - pathology (3) 3
protein kinase inhibitors - adverse effects (3) 3
radiation-therapy (3) 3
receptor protein-tyrosine kinases - genetics (3) 3
reports (3) 3
solid tumors (3) 3
acquired-resistance (2) 2
aged, 80 and over (2) 2
alectinib (2) 2
anaplastic lymphoma kinase (2) 2
article (2) 2
brain tumors (2) 2
breast-cancer (2) 2
carbazoles - therapeutic use (2) 2
cell lung-cancer (2) 2
central nervous system (2) 2
disease-free survival (2) 2
egfr (2) 2
eml4-alk fusion gene (2) 2
erlotinib (2) 2
gefitinib (2) 2
genes (2) 2
kinases (2) 2
lung neoplasms - genetics (2) 2
magnetic resonance imaging (2) 2
motexafin gadolinium (2) 2
mutation (2) 2
nsclc (2) 2
ovarian cancer (2) 2
patients (2) 2
pharmaceutical industry (2) 2
phase-iii (2) 2
piperidines - therapeutic use (2) 2
pyrimidines - adverse effects (2) 2
radiation (2) 2
randomized-trial (2) 2
receptor protein-tyrosine kinases - analysis (2) 2
research (2) 2
response evaluation criteria in solid tumors (2) 2
retrospective studies (2) 2
stereotactic radiosurgery (2) 2
studies (2) 2
tumors (2) 2
tyrosine kinase inhibitors (2) 2
1st-line treatment (1) 1
2p23 (1) 1
activating mutations (1) 1
adenocarcinoma (1) 1
adolescent (1) 1
adult patients pts (1) 1
afatinib (1) 1
affected relative pairs (1) 1
alanine (1) 1
alanine transaminase (1) 1
alanine transaminase - blood (1) 1
anaplastic lymphoma (1) 1
antibodies, monoclonal - pharmacology (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - pharmacology (1) 1
apoptosis - drug effects (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 4, pp. 452 - 463
Journal Article
Journal Article
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 10, pp. 1011 - 1019
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 2, pp. 234 - 242
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 11, pp. 1004 - 1012
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 12, pp. 1683 - 1696
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 82, pp. 27 - 33
Journal Article